651 related articles for article (PubMed ID: 17877887)
1. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
2. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
3. Management and prevention of recurrent herpes labialis in immunocompetent patients.
Gilbert SC
Herpes; 2007 Dec; 14(3):56-61. PubMed ID: 18371287
[TBL] [Abstract][Full Text] [Related]
4. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
5. Treatment of herpes simplex labialis.
Spruance SL; Kriesel JD
Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
[TBL] [Abstract][Full Text] [Related]
6. Short-course therapy for recurrent genital herpes and herpes labialis.
Spruance S; Aoki FY; Tyring S; Stanberry L; Whitley R; Hamed K
J Fam Pract; 2007 Jan; 56(1):30-6. PubMed ID: 17217895
[No Abstract] [Full Text] [Related]
7. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
8. The natural history of recurrent oral-facial herpes simplex virus infection.
Spruance SL
Semin Dermatol; 1992 Sep; 11(3):200-6. PubMed ID: 1390034
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
10. Single-dose famciclovir for the treatment of herpes labialis.
Hull C; Spruance S; Tyring S; Hamed K
Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
[TBL] [Abstract][Full Text] [Related]
11. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
Harmenberg J; Oberg B; Spruance S
Acta Derm Venereol; 2010 Mar; 90(2):122-30. PubMed ID: 20169294
[TBL] [Abstract][Full Text] [Related]
12. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
13. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
15. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
[TBL] [Abstract][Full Text] [Related]
16. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
17. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
18. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
19. Clinical inquiries. Does acyclovir help herpes simplex virus cold sores if treatment is delayed?
Madigosky WS; Meadows S; McCormack O
J Fam Pract; 2004 Nov; 53(11):923-4. PubMed ID: 15527733
[No Abstract] [Full Text] [Related]
20. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
Pica F; Volpi A; Gaziano R; Garaci E
Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
